Sector
1090 stories · page 33 of 55
Irwin Naturals said it believes the market price of its shares may not fully reflect the underlying value of its business and prospects and that at such times the repurchase of its shares for cancellation represents an appropriate use of th
"I am very pleased with the substantial operational progress the group has made since the launch of our first product in September last year,” said CEO Bob Rauker
For the quarter ended July 31, 2022, the company posted revenue of C$1,160,547, up from $1,131,171 in the year-ago period
"We are working on scaling KetaMD beyond Florida across the US, opening up the opportunity for people to receive care any time, from the comfort of their own homes," said KetaMD CEO Warren Gumpel
"These coordinated regimes at scale can dramatically reduce the incidence and impact of an estimated US$8 trillion of preventable healthcare costs globally,” Wellteq Digital Health CEO Scott Montgomery said
The company has struck a binding deal to acquire, in cash and shares, all of the membership interests in Happier You LLC, which operates a ketamine clinic in central Ohio
Under the arrangement, Wellteq said its shareholders will receive one ordinary share of Advanced Human Imaging (AHI) for every six Wellteq shares or 0.1667 AHI shares for every 1 Wellteq share
“Michigan is a significant step in what is becoming a sprint to put Irwin Naturals THC products on the shelves of dispensaries in all 38 states where cannabis is legalized,” Irwin Naturals CEO Klee Irwin said
Irwin Naturals intends to leverage its brand status to drive an aggressive rollout of mental health clinics, namely ketamine clinics
"We are proud to have launched KetaMD in the US so that we can begin addressing the needs of millions lacking access to innovative treatments for mental health disorders such as depression, anxiety, bipolar disorder and post-traumatic stres
The firm said it has selected a final lead drug candidate from a short list of six DMT analogues and intends to submit the patent in the fourth quarter this year
The Canadian medical cannabis service provider saw revenues improved quarter-over-quarter after pandemic restrictions were eased
The FDA's no-objection acknowledgement letter is the highest safety rating and attestation the client can achieve for its dietary ingredient, Wellbeing Digital Sciences said
IRP Health's Reactivation program hopes to reduce patient disability in the short and long term, while giving veterans better control and understanding of their pain and health challenges
"After analyzing the operations of our TMC clinics and taking into consideration the potential for future growth, we've decided that both Hamilton and Mississauga clinics do not fully meet our expansion goals", Steven McAuley, chairman and
“We believe focusing on expanding our network of clinics will provide the company with a larger footprint to roll out new treatments as they become approved by the Food and Drug Administration and Health Canada,” said Wellbeing CEO Najla Gu
The de novo pathway is specifically designed for novel medical devices
“We’re moving fast right now to take advantage of this opportunity to be the first national brand in this space, establishing ourselves as the first name people will think of when it comes to receiving these life-changing treatments,” Irwin
“The vision we laid out for Irwin Naturals Emergence is becoming a reality with each acquisition we announce and execute,” said Irwin Naturals CEO Klee Irwin
The nutraceutical company said Entourage will manufacture the newly-formulated suite of Irwin-branded line of softgels in five different varieties: CBD, THC and three additional formulations that include both THC and another cannabinoid
